251
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis

, BAORCID Icon, , MDORCID Icon, , MDORCID Icon & , MDORCID Icon
Pages 1603-1607 | Received 19 Jul 2021, Accepted 04 May 2022, Published online: 06 Jul 2022

References

  • Brady CJ, Villanti AC, Law HA, et al. Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database Syst Rev. 2016;2016(2). doi:10.1002/14651858.CD010469.pub2. Published Online First.
  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713.
  • Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80(9):844–848. doi:10.1136/bjo.80.9.844.
  • Cai CX, Skalak C, Keenan RT, Grewal DS, Jaffe GJ. Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):1023–1030. doi:10.1007/s00417-020-04614-x.
  • Gaballa SA, Kompella UB, Elgarhy O, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2020 Sep 8. doi:10.1007/s13346-020-00843-z. Epub ahead of print. PMID: 32901367.
  • Yu C, MacDougall D. Intravitreal Dexamethasone Implants for Non-infectious Uveitis: A Review of Clinical Effectiveness, Cost-effectiveness, and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Mar 25. PMID: 33074617.
  • Lowder C, Belfort R Jr, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129(5):545–553. doi:10.1001/archophthalmol.2010.339.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005 Sep;140(3):509–516. doi:10.1016/j.ajo.2005.03.057. PMID: 16196117.
  • Modorati G, Miserocchi E. Intravitreal injection therapy in the treatment of noninfectious uveitis. Dev Ophthalmol. 2012;51:110–121. doi:10.1159/000336471.
  • Jaffe GJ, Pavesio CE, Study Investigators. Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis: three-year results. Ophthalmol. 2020 Oct;127(10):1395–1404. doi:10.1016/j.ophtha.2020.04.001. Epub 2020 Apr 17. PMID: 32624244.
  • Jaffe GJ, Lin P, Keenan RT, Ashton P, Skalak C, Stinnett SS. Injectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis: two-year results. Ophthalmol. 2016 Sep;123(9):1940–1948. doi:10.1016/j.ophtha.2016.05.025. Epub 2016 Jul 13. PMID: 27421623.
  • Dick AD, Tundia N, Sorg R, et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmol. 2016 Mar;123(3):655–662. doi:10.1016/j.ophtha.2015.10.028. Epub 2015 Dec 19. Erratum in: Ophthalmology. 2016 Nov;123(11):2439. PMID: 26712559.
  • Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996 Apr;80(4):332–336. doi:10.1136/bjo.80.4.332. PMID: 8703885; PMCID: PMC505460.
  • Vieira R, Sousa-Pinto B, Figueira L. Efficacy and safety of corticosteroid implants in non-infectious uveitis: a systematic review with network meta-analysis [published online ahead of print, 2020 Aug 18]. Ocul Immunol Inflamm. 2020;1–8. doi:10.1080/09273948.2020.1787463.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.